Australia Genomics Market

Australia Genomics Market Overview:

The Australia genomics market size reached USD 1.08 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.92 Billion by 2033, exhibiting a growth rate (CAGR) of 13.80% during 2025-2033. The market is driven by the growing demand for personalized medicine, government investment in national genomics programs, advancements in sequencing technologies, and increased awareness of genetic testing benefits. Collaboration between research institutions and healthcare providers also fuels innovation, making genomics more accessible and clinically relevant thus supporting the Australia genomics market share.

Australia Genomics Market Trends:

AI-Driven Genomics: Advancing Precision Medicine

The use of artificial intelligence (AI) in genomics is transforming the diagnosis and treatment of diseases in Australia. AI facilitates fast analysis of intricate genetic information, allowing researchers and clinicians to detect mutations and patterns associated with different conditions. This aids in the creation of personalized medicine, with treatments being customized to the genetic makeup of each individual. In June 2024, the Australian Government invested A$57 million to drive research in AI and genomics with the goal of improving diagnostic accuracy and speeding up the uptake of precision treatments. In the clinic, AI is already enhancing decision-making and shortening delays in diagnosis. Although the potential is huge, there are challenges specifically around ethical use of data and the requirement for transparent regulation. However, AI genomics is likely to transform cancer, rare disease, and inherited disorder care across the country further propelling the Australia genomics market growth.

National Genomics Integration: A Move Toward Equitable Access

Australia is undertaking a nationwide effort to integrate genomics into everyday healthcare, aiming to make advanced diagnostics and treatments accessible to all citizens. By building infrastructure and extending services into regional and remote areas, the country seeks to bridge the healthcare gap between urban and rural populations. These efforts are supported by significant government investment, including over 25 funded projects focused on improving testing, diagnosis, and reducing unnecessary interventions and healthcare costs. Initiatives are being developed to embed genomic testing into routine medical care, enhancing early detection and enabling more personalized treatment plans across diverse communities. Central to this transformation is collaboration among federal and state health systems, research bodies, and clinical providers. While challenges like workforce readiness and system integration remain, the overarching goal is to deliver equitable, effective, and future-focused care through genomics nationwide.

Growing Demand for Precision Genomic Testing

Precision genomic testing is picking up speed throughout Australia as patients and healthcare providers are looking for more personalized treatment. The tests identify unique genetic factors that can lead to diseases, so more targeted treatment regimens can be used. This is particularly effective with cancer treatment and rare genetic disorders, where typical diagnostics can be ineffective. Increased sensitivity to personalized medicine and technological advancement have made genomics testing easier and more attainable. The services are now being incorporated in routine diagnostics within healthcare institutions due to government interventions and innovation within the private sector. With additional clinicians embracing precision testing, the future holds promising to revolutionize treatment strategies as healthcare becomes proactive, accurate, and customized based on individual patient genetic profile.

Australia Genomics Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2025-2033. Our report has categorized the market based on component, application, technology, and end-user.

Component Insights:

• Products
  • Instruments and Software
  • Consumables and Reagents
• Services
  • Core Genomics Services
  • NGS-Based Services
  • Biomarker Translation Services
  • Computational Services
  • Others

The report has provided a detailed breakup and analysis of the market based on the component. This includes products (instruments and software and consumables and reagents) and services (core genomics services, NGS-based services, biomarker translation services, computational services, and others).

Application Insights:

• Functional Genomics
• Epigenomics
• Biomarkers Discovery
• Pathway Analysis
• Others

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes functional genomics, epigenomics, biomarkers discovery, pathway analysis, and others.

Technology Insights:

• Sequencing
• Microarray
• Polymerase Chain Reaction
• Nucleic Acid Extraction and Purification
• Others

The report has provided a detailed breakup and analysis of the market based on the technology. This includes sequencing, microarray, polymerase chain reaction, nucleic acid extraction and purification, and others.

End-User Insights:

• Research Centers
• Hospitals and Clinics
• Pharmaceutical and Biotechnology Companies
• Others

A detailed breakup and analysis of the market based on the end-user have also been provided in the report. This includes research centers, hospitals and clinics, pharmaceutical and biotechnology companies, and others.

Regional Insights:

• Australia Capital Territory & New South Wales
• Victoria & Tasmania
• Queensland
• Northern Territory & Southern Australia
• Western Australia

The report has also provided a comprehensive analysis of all the major regional markets, which include Australia Capital Territory & New South Wales, Victoria & Tasmania, Queensland, Northern Territory & Southern Australia, and Western Australia.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Australia Genomics Market News:

• In March 2025, Parse Biosciences expanded its global reach by welcoming the South Australian Genomics Centre (SAGC) as a Certified Service Provider (CSP). This partnership allows Australian and Asia-Pacific researchers access to Parse’s scalable, cost-effective single cell sequencing technology. The CSP Program, launched in 2024, ensures high-quality solutions for small to large-scale genomic projects, supporting scientific discoveries. Dr. Sen Wang, SAGC Centre Manager, highlights the technology's rapid adoption in Australia.
• In April 2024, Transcendomics, launch aims to scale clinical genomics across Australia using Genomical®, a software platform developed by Melbourne Genomics. Genomical enables secure, efficient genomic data use by integrating with healthcare systems and simplifying complex testing. Already supporting over 20,000 tests, it addresses major data challenges for labs. Transcendomics now seeks industry partners to expand access, as demand for genomic testing and precision medicine continues to grow nationwide.

Australia Genomics Market Report Coverage:

Key Questions Answered in This Report:

• How has the Australia genomics market performed so far and how will it perform in the coming years?
• What is the breakup of the Australia genomics market on the basis of component?
• What is the breakup of the Australia genomics market on the basis of application?
• What is the breakup of the Australia genomics market on the basis of technology?
• What is the breakup of the Australia genomics market on the basis of end-user?
• What is the breakup of the Australia genomics market on the basis of region?
• What are the various stages in the value chain of the Australia genomics market? 
• What are the key driving factors and challenges in the Australia genomics market?
• What is the structure of the Australia genomics market and who are the key players?
• What is the degree of competition in the Australia genomics market? 

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Australia genomics market from 2019-2033.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the Australia genomics market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Australia genomics industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.